If acne on your face and back is part of your skin-care discussion during GLP-1 treatment, tell the dermatologist about both areas. The trifarotene studies assessed them separately. They do not establish that GLP-1 treatment caused the breakouts or that an acne cream restores facial fullness.

Two trials evaluated the face and trunk

Tan and colleagues reported two 12-week randomized, double-blind studies comparing trifarotene 50 micrograms per gram cream with its vehicle in people aged nine and older with moderate facial and truncal acne. Facial success and lesion-count changes were primary outcomes; corresponding trunk measures were secondary outcomes. Adjunctive topical or systemic treatments were not studied. [2]

We reviewed the journal abstract rather than the full report, which could not be accessed. Some authors had Galderma research-and-development affiliations; the full funding and conflict disclosures were not verified. The abstract does not establish that this medicine is better than another active acne treatment. [2]

Keep the treatment area with each result

The U.S. label describes 2,420 participants, 87% White and 55% female. At week 12, success required a clear or almost-clear rating and at least a two-grade improvement. The reported success rates were: [1]

Study / areaTrifaroteneVehicle
1: face29.4%19.5%
1: trunk35.7%25.0%
2: face42.3%25.7%
2: trunk42.6%29.9%

The label reports face and trunk analyses separately. These success percentages count participants meeting a defined rating; they are not percentages of individual pimples removed. [1]

For a consultation, write down where the acne bothers you and which concern you want addressed. Ask whether the proposed plan covers the face, chest, shoulders, back or a combination. Keep the clinician's instructions for each area with your prescription.

If you are comparing treatment options, ask for evidence about the same condition, treatment area and outcome. A percentage about a face rating should not be presented as the expected chance of clearing every affected area.

Plan for irritation before starting

AKLIEF is trifarotene 0.005%, a U.S. prescription acne treatment for ages nine and older. Its instructions recommend moisturizer from treatment initiation. Redness, scaling, dryness and stinging or burning can occur; tell the prescriber about reactions so frequency changes, a pause or discontinuation can be considered. [1]

The label advises avoiding damaged, eczematous or sunburned skin, waxing treated areas, potentially irritating products and unprotected UV exposure. Disclose pregnancy plans, breastfeeding, other medicines and acne products before use. [1]

Bring the cleanser, exfoliant, spot treatment and occasional products you use, rather than describing the routine as simply “skin care.” Ask which belong alongside this prescription and what to do if discomfort develops. Follow the instructions for your product instead of adding applications to meet an event date.

Include clothing and cleansing in the discussion

AAD's back-acne guidance recommends gentle cleansing, avoiding harsh scrubs and abrasive tools, changing out of sweaty clothing and reducing friction from items such as backpacks. It advises non-comedogenic, broad-spectrum, water-resistant SPF 30 sunscreen and dermatology assessment for deep, painful acne. [3]

Explain any practical difficulty reaching the affected area or fitting treatment into your day. Ask the prescriber or pharmacist to demonstrate the intended application method and amount for your exact package. Do not assume an inaccessible patch of back has received treatment simply because the front of the routine is consistent.

Our back-breakout and workout-care guide covers the everyday-care question. Our retinol and tretinoin evidence guide concerns different ingredients and study outcomes.

Agree on the review before judging the result

Ask when the dermatologist wants to assess your course and how to record progress in each treated area. A dated note can include the instructions followed, missed applications, irritation and the symptom or appearance concern you hoped to improve.

If a regimen is difficult to follow or uncomfortable, report that at review. Those details help distinguish the treatment decision from a comparison of photographs alone. Ask what would justify continuing, adjusting or choosing another approach.

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.

Sources

  1. AKLIEF: trifarotene cream, U.S. prescribing and patient informationDailyMed; posted September 2024, revised October 2023; checked October 29, 2026↩ Back to text
  2. Trifarotene for moderate facial and truncal acne: two randomized studiesTan and colleagues, JAAD, 2019; abstract reviewed↩ Back to text
  3. Back acne: How to see clearer skinAmerican Academy of Dermatology; updated September 2023, checked October 29, 2026↩ Back to text